Literature DB >> 9399851

Software and database for the analysis of mutations in the human WT1 gene.

C Jeanpierre1, C Béroud, P Niaudet, C Junien.   

Abstract

The WT1 gene, located at 11p13, encodes a zinc finger transcription factor involved in renal and gonadal development and in Wilms' tumor. Constitutional mutations of this gene have been described in most patients with Denys Drash syndrome (mesangial sclerosis associated with male pseudohermaphrodism and/or Wilms' tumor), but also in patients with genitourinary abnormalities and Wilms' tumor (WT) or presenting with only unilateral or bilateral WT. Moreover, approximately 10% of Wilms' tumors carry WT1 mutations at the somatic level. To facilitate the genotype-phenotype correlation analyses, we have created a software package along with a computerized database of germline (70 entries) and somatic (28 entries) mutations reported in the literature.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9399851      PMCID: PMC147190          DOI: 10.1093/nar/26.1.271

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  51 in total

1.  Software and database for the analysis of mutations in the human LDL receptor gene.

Authors:  M Varret; J P Rabès; G Collod-Béroud; C Junien; C Boileau; C Béroud
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

2.  DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1.

Authors:  I A Drummond; H D Rupprecht; P Rohwer-Nutter; J M Lopez-Guisa; S L Madden; F J Rauscher; V P Sukhatme
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

3.  The Wilms' tumor suppressor gene WT1 is negatively autoregulated.

Authors:  H D Rupprecht; I A Drummond; S L Madden; F J Rauscher; V P Sukhatme
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

4.  A novel zinc finger mutation in a patient with Denys-Drash syndrome.

Authors:  P N Baird; J K Cowell
Journal:  Hum Mol Genet       Date:  1993-12       Impact factor: 6.150

5.  WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion.

Authors:  N Bardeesy; B Zabel; K Schmitt; J Pelletier
Journal:  Genomics       Date:  1994-06       Impact factor: 5.736

6.  Fine structure analysis of the WT1 gene in sporadic Wilms tumors.

Authors:  R Varanasi; N Bardeesy; M Ghahremani; M J Petruzzi; N Nowak; M A Adam; P Grundy; T B Shows; J Pelletier
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  Database and software for the analysis of mutations in the human p53 gene.

Authors:  N F Cariello; L Cui; C Beroud; T Soussi
Journal:  Cancer Res       Date:  1994-08-15       Impact factor: 12.701

8.  Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.

Authors:  Z Y Wang; Q Q Qiu; J Huang; M Gurrieri; T F Deuel
Journal:  Oncogene       Date:  1995-02-02       Impact factor: 9.867

9.  WT1 exon 1 deletion/insertion mutations in Wilms tumor patients, associated with di- and trinucleotide repeats and deletion hotspot consensus sequences.

Authors:  V Huff; N Jaffe; G F Saunders; L C Strong; F Villalba; E C Ruteshouser
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

10.  Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.

Authors:  M Gessler; A König; K Arden; P Grundy; S Orkin; S Sallan; C Peters; S Ruyle; J Mandell; F Li
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

View more
  8 in total

Review 1.  Frasier and Denys-Drash syndromes: different disorders or part of a spectrum?

Authors:  A Koziell; R Grundy
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

2.  Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1.

Authors:  D J Richard; V Schumacher; B Royer-Pokora; S G Roberts
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

3.  A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome.

Authors:  Thatiana Evilen da Silva; Mirian Yumie Nishi; Elaine Maria Frade Costa; Regina Matsunaga Martin; Filomena Marino Carvalho; Berenice Bilharinho Mendonca; Sorahia Domenice
Journal:  Pediatr Nephrol       Date:  2011-05-11       Impact factor: 3.714

Review 4.  Genetics of pediatric renal tumors.

Authors:  Brigitte Royer-Pokora
Journal:  Pediatr Nephrol       Date:  2012-03-30       Impact factor: 3.714

Review 5.  WT1 and glomerular diseases.

Authors:  Patrick Niaudet; Marie-Claire Gubler
Journal:  Pediatr Nephrol       Date:  2006-08-23       Impact factor: 3.714

6.  Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.

Authors:  C Jeanpierre; E Denamur; I Henry; M O Cabanis; S Luce; A Cécille; J Elion; M Peuchmaur; C Loirat; P Niaudet; M C Gubler; C Junien
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

7.  WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis.

Authors:  Y Yang; C Jeanpierre; G R Dressler; M Lacoste; P Niaudet; M C Gubler
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

8.  New mutation in WT1 gene in a boy with an incomplete form of Denys-Drash syndrome: A CARE-compliant case report.

Authors:  Nail R Akramov; Rafael F Shavaliev; Ilsiya V Osipova
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.